| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.1M | — | +59.3% |
| Cost of Revenue | $14.2M | — | +93.0% |
| Gross Profit | $10.9M | — | +29.8% |
| R&D Expense | $12.8M | — | +47.7% |
| SG&A Expense | $9.7M | — | +15.5% |
| Operating Income | -$11.7M | — | -33.7% |
| Pre-tax Income | -$10.2M | — | -22.8% |
| Income Tax | $3K | — | -25.0% |
| Net Income | -$10.2M | — | -22.8% |
| EPS (Basic) | -$0.50 | — | +97.4% |
| EPS (Diluted) | -$0.50 | — | +97.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $204.5M | +45.8% | — |
| Accounts Receivable | $11.0M | +50.6% | — |
| Inventory | $23.5M | +38.5% | — |
| Current Assets | $241.7M | +43.9% | — |
| Total Assets | $259.5M | +40.5% | — |
| Current Liabilities | $20.6M | +7.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | -894.7% |
| Investing Cash Flow | -$4.0M | — | -260.3% |
| Financing Cash Flow | $79.4M | — | — |
| Total Liabilities | $24.4M | +9.6% | — |
| Stockholders' Equity | $235.2M | +44.7% | +178.5% |